Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Parallel Session 2202

Advances in Neurorehabilitation in Movement Disorders

Saturday, March 22, 2025
14:30 - 16:30 | Room TBD

In this session, the faculty will discuss the elements of a comprehensive, proactive rehabilitation program for movement disorders. They will explore the latest applications of technology. The session will also cover the latest advances in physiotherapy and the use of botulinum toxin to treat various troublesome symptoms in movement disorders.


Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Discuss the applications of technological advances such as artificial intelligence, virtual reality, and robot-assisted tools in the rehabilitation of patients with movement disorders.
  2. Appraise the role of botulinum toxin treatment, including difficult-to-treat dystonia, spasticity, pain, and autonomic dysfunction (e.g., drooling of saliva, overactive bladder).
  3. Understand the latest advances and benefits of physiotherapy for treating motor symptoms as well as non-motor symptoms in movement disorders.

Recommended Audience
Clinical Academicians
Non-Physician Health Professionals
Practitioners
Students/Residents/Trainees

Education Level

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice